ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

MORF Morphic Holding Inc

29.90
1.19 (4.14%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Morphic Holding Inc MORF NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
1.19 4.14% 29.90 19:00:00
Open Price Low Price High Price Close Price Previous Close
29.85 29.075 30.30 29.90 28.71
more quote information »

Recent News

Date Time Source Heading
4/25/202406:00GLOBEMorphic Announces Corporate Highlights and Financial Results..
3/19/202407:00GLOBEMorphic Appoints Dr. Simon Cooper as Chief Medical Officer
3/05/202415:05GLOBEMorphic to Participate in March Investor Conferences
2/22/202406:46EDGAR2Form S-8 - Securities to be offered to employees in employee..
2/22/202406:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/22/202406:04EDGAR2Form 8-K - Current report
2/22/202406:00GLOBEMorphic Announces Corporate Highlights and Financial Results..
1/17/202418:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/17/202418:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/17/202418:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/17/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202415:08EDGAR2Form 8-K - Current report
1/03/202415:05GLOBEMorphic to Present at the 42nd Annual J.P. Morgan Healthcare..
12/06/202307:57EDGAR2Form 8-K - Current report
11/10/202307:00GLOBEMorphic to Present at November Investor Conferences
11/03/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/03/202306:13EDGAR2Form 8-K - Current report
11/03/202306:00GLOBEMorphic Announces Corporate Highlights and Financial Results..
10/12/202307:52EDGAR2Form 8-K - Current report
10/09/202307:00GLOBEMorphic Therapeutic to Host Webcast to Present EMERALD-1..
9/26/202316:30EDGAR2Form 8-K - Current report
9/26/202315:10GLOBEMorphic Holdings Announces CEO Dr. Praveen Tipirneni to Take..
9/22/202316:30GLOBEMorphic to Present Positive EMERALD-1 Phase 2a Data for..
9/08/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/07/202315:24EDGAR2Form 144 - Report of proposed sale of securities
8/29/202307:00GLOBEMorphic Announces Participation in 2023 Wells Fargo..
8/09/202315:05GLOBEMorphic to Present at the Canaccord Genuity 43rd Annual..
8/03/202317:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/03/202306:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/202306:08EDGAR2Form 8-K - Current report
8/03/202306:05GLOBEMorphic Announces Corporate Highlights and Financial Results..
7/06/202318:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/06/202315:05GLOBEMorphic to Present at the Jefferies Global Healthcare..
5/12/202307:30GLOBEMorphic to Present at 2023 RBC Capital Markets Global..
5/11/202307:00GLOBEMorphic Presents New Biomarker Data at DDW 2023 Supporting..

Your Recent History

Delayed Upgrade Clock